Genetic variation in 5-hydroxytryptamine transporter expression causes adaptive changes in 5-HT4 receptor levels

International Journal of Neuropsychopharmacology

Volumn 15, Issue 8, 2012, Pages 1099-1107

  Jennings, Katie Ann ^a   Licht, Cecilie L̈e ^b   Bruce, Aynsley ^c   Lesch, Klaus Peter ^d   Knudsen, Gitte Moos ^b   Sharp, Trevor ^c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b Rigshospitalet   (Denmark)

^c OX1 3QT   (United Kingdom)

^d Department of Psychiatry Psychosomatics and Psychotherapy ^*  (Germany)

Author keywords

5 HT; Autoradiography; SERT; transgenic; transporter

Indexed keywords

FENCLONINE; FLUOXETINE; RADIOLIGAND; SEROTONIN; SEROTONIN 4 RECEPTOR; SEROTONIN TRANSPORTER;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BINDING SITE; BRAIN REGION; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOTE; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; WILD TYPE;

ANALYSIS OF VARIANCE; ANIMALS; AUTORADIOGRAPHY; BRAIN; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUOXETINE; GENE EXPRESSION REGULATION; GENETIC VARIATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PIPERIDINES; PROPANE; PROTEIN BINDING; RECEPTORS, SEROTONIN, 5-HT4; SEROTONIN AGENTS; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEROTONIN UPTAKE INHIBITORS; TRITIUM;

EID: 84864540931     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145711001258     Document Type: Article

References (49)

1. Basselin M, Fox MA, Chang L, Bell JM, et al. (2009). Imaging elevated brain arachidonic acid signaling in unanesthetized serotonin transporter (5-HTT)-deficient mice. Neuropsychopharmacology 34, 1695-1709.
2. Bengel D, Murphy DL, Andrews AM, Wichems CH, et al. (1998). Altered brain serotonin homeostasis and locomotor insensitivity to 3, 4- methylenedioxymethamphetamine ('Ecstasy') in serotonin transporter-deficient mice. Molecular Pharmacology 53, 649-655.
3. Bortolozzi A, Amargos-Bosch M, Toth M, Artigas F, et al. (2004). In vivo efflux of serotonin in the dorsal raphe nucleus of 5-HT1A receptor knockout mice. Journal of Neurochemistry 88, 1373-1379.
4. Bouali S, Evrard A, Chastanet M, Lesch KP, et al. (2003). Sex hormone-dependent desensitization of 5-HT1A autoreceptors in knockout mice deficient in the 5-HT transporter. European Journal of Neuroscience 18, 2203-2212.
5. Caccia S, Cappi M, Fracasso C, Garattini S (1990). Influence of dose and oral route of administration on the kinetics of fluoxetine and its metabolite norfluoxetine in the rat. Psychopharmacology (Berlin) 100, 509-514.
6. Compan V, Dusticier N, Nieoullon A, Daszuta A (1996a). Opposite changes in striatal neuropeptide y immunoreactivity after partial and complete serotonergic depletion in the rat. Synapse 24, 87-96.
7. Compan V, Daszuta A, Salin P, Sebben M, et al. (1996b). Lesion study of the distribution of serotonin 5-HT4 receptors in rat basal ganglia and hippocampus. European Journal Neuroscience 8, 2591-2598.
8. Compan V, Zhou M, Grailhe R, Gazzara RA, et al. (2004). Attenuated response to stress and novelty and hypersensitivity to seizures in 5-HT4 receptor knock-out mice. Journal of Neuroscience 24, 412-419.
9. Erritzoe D, Holst K, Frokjaer VG, Licht CL, et al. (2010). A nonlinear relationship between cerebral serotonin transporter and 5-HT(2A) receptor binding: an in vivo molecular imaging study in humans. Journal of Neuroscience 30, 3391-3397.
10. Ettrup A, Kornum BR, Weikop P, Knudsen GM (2011). An approach for serotonin depletion in pigs: effects on serotonin receptor binding. Synapse 65, 136-145.
11. Fabre V, Beaufour C, Evrard A, Rioux A, et al. (2000). Altered expression and functions of serotonin 5-HT1A and 5-HT1B receptors in knock-out mice lacking the 5-HT transporter. European Journal of Neuroscience 12, 2299-2310.
12. Fox MA, Stein AR, French HT, Murphy DL (2010). Functional interactions between 5-HT2A and presynaptic 5-HT1A receptor-based responses in mice genetically deficient in the serotonin 5-HT transporter (SERT). British Journal of Pharmacology 159, 879-887.
13. Franklin KB, Paxinos G (1997). The Mouse Brain in Stereotaxic Coordinates. San Diego: Academic Press.
14. Gobbi G, Murphy DL, Lesch K, Blier P (2001). Modifications of the serotonergic system in mice lacking serotonin transporters: an in vivo electrophysiological study. Journal of Pharmacology and Experimental Therapeutics 296, 987-995.
15. Greenberg BD, Tolliver TJ, Huang SJ, Li Q, et al. (1999). Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets. American Journal of Medical Genetics 88, 83-87.
16. Heils A, Teufel A, Petri S, Stober G, et al. (1996). Allelic variation of human serotonin transporter gene expression. Journal of Neurochemistry 66, 2621-2624.
17. Holladay JW, Dewey MJ, Yoo SD (1998). Pharmacokinetics and antidepressant activity of fluoxetine in transgenic mice with elevated serum alpha-1-acid glycoprotein levels. Drug Metabolism and Disposition 26, 20-24.
18. Holmes A, Murphy DL, Crawley JN (2002a) Reduced aggression in mice lacking the serotonin transporter. Psychopharmacology (Berlin) 161, 160-167.
19. Holmes A, Murphy DL, Crawley JN (2003). Abnormal behavioral phenotypes of serotonin transporter knockout mice: parallels with human anxiety and depression. Biological Psychiatry 54, 953-959.
20. Holmes A, Yang RJ, Murphy DL, Crawley JN (2002b). Evaluation of antidepressant-related behavioral responses in mice lacking the serotonin transporter. Neuropsychopharmacology 27, 914-923.
21. Huang YY, Kandel ER (2007). 5-Hydroxytryptamine induces a protein kinase a/mitogen-activated protein kinase-mediated and macromolecular synthesis-dependent late phase of long-term potentiation in the amygdala. Journal of Neuroscience 27, 3111-3119.
22. Jennings KA, Lesch KP, Sharp T, Cragg SJ (2010). Non-linear relationship between 5-HT transporter gene expression and frequency sensitivity of 5-HT signals. Journal of Neurochemistry 115, 965-973.
23. Jennings KA, Loder MK, Sheward WJ, Pei Q, et al. (2006). Increased expression of the 5-HT transporter confers a low-anxiety phenotype linked to decreased 5-HT transmission. Journal of Neuroscience 26, 8955-8964.
24. Jennings KA, Sheward WJ, Harmar AJ, Sharp T (2008). Evidence that genetic variation in 5-HT transporter expression is linked to changes in 5-HT2A receptor function. Neuropharmacology 54, 776-783.
25. Knobelman DA, Hen R, Lucki I (2001). Genetic regulation of extracellular serotonin by 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B) autoreceptors in different brain regions of the mouse. Journal of Pharmacology and Experimental Therapeutics 298, 1083-1091.
26. Kornum BR, Licht CL, Weikop P, Knudsen GM, et al. (2006). Central serotonin depletion affects rat brain areas differently: a qualitative and quantitative comparison between different treatment schemes. Neuroscience Letters 392, 129-134.
27. Lesch KP, Bengel D, Heils A, Sabol SZ, et al. (1996). Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274, 1527-1531.
28. Licht CL, Kirkegaard L, Zueger M, Chourbaji S, et al. (2010). Changes in 5-HT4 receptor and 5-HT transporter binding in olfactory bulbectomized and glucocorticoid receptor heterozygous mice. Neurochemistry International 56, 603-610.
29. Licht CL, Marcussen AB, Wegener G, Overstreet DH, et al. (2009). The brain 5-HT4 receptor binding is down-regulated in the flinders sensitive line depression model and in response to paroxetine administration. Journal of Neurochemistry 109, 1363-1374.
30. Lucas G, Rymar VV, Du J, Mnie-Filali O, et al. (2007). Serotonin(4) (5-HT(4)) receptor agonists are putative antidepressants with a rapid onset of action. Neuron 55, 712-725.
31. Lundberg J, Christophersen JS, Petersen KB, Loft H, et al. (2007). PET measurement of serotonin transporter occupancy: a comparison of escitalopram and citalopram. International Journal of Neuropsychopharmacology 10, 777-785.
32. Mannoury la Cour C, Boni C, Hanoun N, Lesch KP, et al. (2001). Functional consequences of 5-HT transporter gene disruption on 5-HT(1a) receptor-mediated regulation of dorsal raphe and hippocampal cell activity. Journal of Neuroscience 21, 2178-2185.
33. Marner L, Gillings N, Comley RA, Baare WF, et al. (2009). Kinetic modeling of 11C-SB207145 binding to 5-HT4 receptors in the human brain in vivo. Journal of Nuclear Medicine 50, 900-908.
34. Marner L, Gillings N, Madsen K, Erritzoe D, et al. (2010). Brain imaging of serotonin 4 receptors in humans with 11CSB207145-PET. Neuroimage 50, 855-861.
35. Mathews TA, Fedele DE, Coppelli FM, Avila AM, et al. (2004). Gene dose-dependent alterations in extraneuronal serotonin but not dopamine in mice with reduced serotonin transporter expression. Journal of Neuroscience Methods 140, 169-181.
36. Ogilvie AD, Battersby S, Bubb VJ, Fink G, et al. (1996). Polymorphism in serotonin transporter gene associated with susceptibility to major depression. Lancet 347, 731-733.
37. Ozaki N, Goldman D, Kaye WH, Plotnicov K, et al. (2003). Serotonin transporter missense mutation associated with a complex neuropsychiatric phenotype. Molecular Psychiatry 8, 933-936.
38. Paterson LM, Tyacke RJ, Nutt DJ, Knudsen GM (2010). Measuring endogenous 5-HT release by emission tomography: promises and pitfalls. Journal of Cerebral Blood Flow and Metabolism 30, 1682-1706.
39. Qu Y, Villacreses N, Murphy DL, Rapoport SI (2005). 5-HT2A/2C receptor signaling via phospholipase A2 and arachidonic acid is attenuated in mice lacking the serotonin reuptake transporter. Psychopharmacology (Berlin) 180, 12-20.
40. Rhodes RA, Murthy NV, Dresner MA, Selvaraj S, et al. (2007). Human 5-HT transporter availability predicts amygdala reactivity in vivo. Journal of Neuroscience 27, 9233-9237.
41. Sah P, Westbrook RF, Luthi A (2008). Fear conditioning and long-term potentiation in the amygdala: what really is the connection? Annals of the New York Academy of Sciences 1129, 88-95.
42. Shen HW, Hagino Y, Kobayashi H, Shinohara-Tanaka K, et al. (2004). Regional differences in extracellular dopamine and serotonin assessed by in vivo microdialysis in mice lacking dopamine and/or serotonin transporters. Neuropsychopharmacology 29, 1790-1799.
43. Sigurdsson T, Doyere V, Cain CK, LeDoux JE (2007). Long-term potentiation in the amygdala: a cellular mechanism of fear learning and memory. Neuropharmacology 52, 215-227.
44. Varnas K, Halldin C, Pike VW, Hall H (2003). Distribution of 5-HT4 receptors in the postmortem human brain-an autoradiographic study using 125ISB 207710. European Neuropsychopharmacology 13, 228-234.
45. Vidal R, Valdizan EM, Mostany R, Pazos A, et al. (2009). Long-term treatment with fluoxetine induces desensitization of 5-HT4 receptor-dependent signalling and functionality in rat brain. Journal of Neurochemistry 110, 1120-1127.
46. Vidal R, Valdizan EM, Vilaro MT, Pazos A, et al. (2010). Reduced signal transduction by 5-HT4 receptors after long-term venlafaxine treatment in rats. British Journal of Pharmacology 161, 695-706.
47. Waeber C, Sebben M, Bockaert J, Dumuis A (1996). Regional distribution and ontogeny of 5-HT4 binding sites in rat brain. Behavioural Brain Research 73, 259-262.
48. Warner-Schmidt JL, Flajolet M, Maller A, Chen EY, et al. (2009). Role of p11 in cellular and behavioral effects of 5-HT4 receptor stimulation. Journal of Neuroscience 29, 1937-1946.
49. WellmanCL, Izquierdo A, Garrett JE, Martin KP, et al. (2007). Impaired stress-coping and fear extinction and abnormal corticolimbic morphology in serotonin transporter knock-out mice. Journal of Neuroscience 27, 684-691.